Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

103.08 -0.23 (-0.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,417,767
Open 101.93
Bid (Size) 102.35 (2)
Ask (Size) 102.80 (32)
Prev. Close 103.31
Today's Range 100.92 - 103.68
52wk Range 95.02 - 217.25
Shares Outstanding 381,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich. 
Via InvestorPlace
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety

Performance

YTD
-42.41%
-42.41%
1 Month
-5.74%
-5.74%
3 Month
-16.56%
-16.56%
6 Month
-34.14%
-34.14%
1 Year
-14.80%
-14.80%

More News

Read More
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Via Benzinga
Exposures COVID-19 Product Safety
Moderna Unusual Options Activity For October 03
Via Benzinga
Is Pfizer Stock a Buy Now?
Via The Motley Fool
Check Out What Whales Are Doing With MRNA
Via Benzinga
Looking Into Moderna's Recent Short Interest
Via Benzinga
2 Top Biotech Stocks to Buy in October
Via The Motley Fool
Have The Bulls Returned? Get Prepared For October And Q4 With Markets With Mando!
Via Benzinga
Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19
Via Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Via The Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
Via The Motley Fool
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
Via The Motley Fool
Exposures COVID-19
Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
Via ACCESSWIRE
Why Pfizer and BioNTech Stocks Zoomed Higher Today
Via The Motley Fool
Exposures COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
If I Could Only Buy 3 Stocks in 2023, I'd Pick These
Via The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
Via Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
Via Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer
Via InvestorPlace
Don’t Miss the Boom: 3 Healthcare Stocks Set to Explode Higher
Via InvestorPlace
Moderna Talks Offer Hope for Enhanced COVID-19 Vaccine Availability In Europe
Via Benzinga
Exposures COVID-19
Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.
Via InvestorPlace
Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.